Predictors of the no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction due to stenotic coronary artery disease
DOI:
https://doi.org/10.14739/2310-1210.2025.2.320492Keywords:
acute myocardial infarction, STEMI, percutaneous coronary intervention, no-reflow phenomenon, risk factorsAbstract
Aim. To identify modifiable and non-modifiable risk factors for no-reflow syndrome in ST-segment elevation myocardial infarction (STEMI) patients undergoing reperfusion by balloon angioplasty.
Materials and methods. We analyzed 392 patients with STEMI who underwent percutaneous coronary intervention (PCI). The patients were divided into 2 groups based on the presence of no-reflow syndrome. Clinical data, laboratory results and instrumental findings were compared between the groups.
Results. A higher proportion of women has been observed among no-reflow patients compared to normal-flow group (33 % versus 22 %, p < 0.05). A lower hemoglobin level has been found in the study group as compared to that in the control group: 132 g/L and 136 g/L, respectively (p < 0.05). However, the same proportion of individuals with anemia has been documented in both groups (p = 0.79). Patients with no-reflow syndrome had lower glomerular filtration rate (GFR) compared to those in the normal-flow group – 61.1 mL/min/1.73 m2 versus 67.9 mL/min/1.73 m2 (p < 0.05). Additionally, GFR <60 mL/min/1.73 m2 has been more common in the study group (48 %) than in the control group (35 %). Lesion types of an infarct-related artery in patients with no-reflow have been presented significantly more often as acute occlusion (78 % versus 65 %, p < 0.05) or thrombotic occlusion / subocclusion (6 % versus 1 %, p < 0.05). In the cases of impeded distal blood circulation during PCI, thrombus extraction was performed in 9 % of patients, compared to only 2 % in the normal blood flow group (p < 0.05). Female sex (OR 1.71 95 % CI 1.01–2.87), thrombus extraction (OR 4.24 95 % CI 1.49–12.05) and a patient belonging to the GFR <60 mL/min/1.73 m2 category (OR 1.66 95 % CI 1.03–2.69) have been identified as the risk factors increasing the chances for developing no-reflow.
Conclusions. Female sex represents a non-modifiable risk factor for the development of no-reflow phenomenon. GFR <60 mL/min/1.73 m2 is a significant modifiable risk factor. Characteristics of the infarct-related artery lesion, such as acute occlusion or thrombotic occlusion / subocclusion, are associated with an increased risk of no-reflow.
References
Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J Acute Cardiovasc Care. 2024;13(1):55-161. doi: https://doi.org/10.1093/ehjacc/zuad107
d'Entremont MA, Alazzoni A, Dzavik V, Sharma V, Overgaard CB, Lemaire-Paquette S, et al. No-reflow after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: an angiographic core laboratory analysis of the TOTAL Trial. EuroIntervention. 2023;19(5):e394-e401. doi: https://doi.org/10.4244/EIJ-D-23-00112
Ministry of Health of Ukraine. Unifikovanyi klinichnyi protokol ekstrenoi, pervynnoi, vtorynnoi (spetsializovanoi), tretynnoi (vysokospetsializovanoi) medychnoi dopomohy ta kardioreabilitatsii "Hostryi koronarnyi syndrom bez elevatsii sehmenta ST" [Unified clinical protocol for emergency, primary, secondary (specialized), tertiary (highly specialized) medical care and cardiac rehabilitation "Acute coronary syndrome with ST segment elevation". Order dated 2021 Sep 15, No. 1957] [Internet]. 2021 [cited 2025 Jan 3]. Ukrainian. Available from: https://zakon.rada.gov.ua/rada/show/v1957282-21?lang=en#Text
Sarkar A, Grigg WS, Lee JJ. TIMI grade flow. StatPearls, Treasure Island (FL): StatPearls Publishing; 2024. http://www.ncbi.nlm.nih.gov/books/NBK482412
Hruzieva TS, Lekhan VM, Ohniev VA, Haliienko LI, Kriachkova LV, Palamar BI, et al. [Biostatistics: textbook]. Vinnytsia, Ukraine: Nova Knyha; 2020. Ukrainian.
Baaten C, Vondenhoff S, Noels H. Endothelial Cell Dysfunction and Increased Cardiovascular Risk in Patients With Chronic Kidney Disease. Circ Res. 2023;132(8):970-92. doi: https://doi.org/10.1161/CIRCRESAHA.123.321752
Ndrepepa G, Kastrati A. Coronary No-Reflow after Primary Percutaneous Coronary Intervention-Current Knowledge on Pathophysiology, Diagnosis, Clinical Impact and Therapy. J Clin Med. 2023;12(17):5592. doi: https://doi.org/10.3390/jcm12175592
Namazi M, Mahmoudi E, Safi M, Jenab Y, Vakili H, Saadat H, et al. The No-reflow Phenomenon: Is it Predictable by Demographic factors and Routine Laboratory Data? Acta Biomed. 2021 Nov 3;92(5):e2021297. doi: https://doi.org/10.23750/abm.v92i5.10053
Yu Y, Wu Y, Wu X, Wang J, Wang C. Risk Factors for No-Reflow in Patients with ST-Elevation Myocardial Infarction Who Underwent Percutaneous Coronary Intervention: A Case-Control Study. Cardiol Res Pract. 2022;2022:3482518. doi: https://doi.org/10.1155/2022/3482518
El Khoudary SR, Nasr A. Cardiovascular Disease in Women: Does Menopause Matter? Curr Opin Endocr Metab Res. 2022;27:100419. doi: https://doi.org/10.1016/j.coemr.2022.100419
Savic L, Mrdovic I, Asanin M, Stankovic S, Lasica R, Krljanac G, et al. The Impact of Kidney Function on the Slow-Flow/No-Reflow Phenomenon in Patients Treated with Primary Percutaneous Coronary Intervention: Registry Analysis. J Interv Cardiol. 2022;2022:5815274. doi: https://doi.org/10.1155/2022/5815274
Bamarinejad F, Kermani-Alghoraishi M, Soleimani A, Roohafza H, Yazdekhasti S, Azarm M, et al. Clinical, laboratory, and procedural predictors of slow flow/no reflow phenomenon after emergency percutaneous coronary interventions in ST-elevated myocardial infarction. Egypt Heart J. 2024;76(1):146. doi: https://doi.org/10.1186/s43044-024-00577-0
Yang L, Cong H, Lu Y, Chen X, Liu Y. Prediction of no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Medicine (Baltimore). 2020;99(26):e20152. doi: https://doi.org/10.1097/MD.0000000000020152
Satti Z, Omari M, Bawamia B, Cartlidge T, Egred M, Farag M, et al. The Use of Thrombectomy during Primary Percutaneous Coronary Intervention: Resurrecting an Old Concept in Contemporary Practice. J Clin Med. 2024;13(8):2291. doi: https://doi.org/10.3390/jcm13082291
Januszek R, Siudak Z, Malinowski KP, Wojdyła R, Mika P, Wańha W, et al. Aspiration Thrombectomy in Patients with Acute Myocardial Infarction-5-Year Analysis Based on a Large National Registry (ORPKI). J Clin Med. 2020;9(11):3610. doi: https://doi.org/10.3390/jcm9113610
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 O. O. Khaniukov, L. V. Sapozhnychenko, O. V. Smolianova, I. D. Bashmakov
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. 
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
